On Monday, Morocco signed agreements to manufacture and package the Chinese COVID-19 vaccine and other vaccines in the Kingdom. The agreement came in a ceremony presided over by King Mohammed VI, at the Royal Palace in the city of Fez.
Three agreements were signed, the first being a memorandum of cooperation on the COVID-19 vaccine between the Moroccan government and the National Pharmaceutical Group of China “Sinopharm”, the second being a memorandum of understanding on the preparation of vaccine manufacturing capabilities in the Kingdom with the Swedish company “Recipharm”, and the third being an agreement between “Sinopharm” and “Sutima” of Morocco, allowing the latter to manufacture the Chinese vaccine.
It is stated that the agreements aim to enable Morocco to produce vaccines, and other major vaccines, to enhance its self-sufficiency.
The agreements aim to produce 5 million doses of the vaccine per month, while gradually doubling itself.
It is said that the vaccine production project in Morocco is expected to mobilize a total investment of about $500 million.
Morocco, which rolled out a COVID-19 vaccination campaign in January, has inoculated more people against the virus than any other African country. The country has administered 23 million doses of the Sinopharm and AstraZeneca vaccines as of July 5.
The Kingdom has received 20.4 million doses so far and plans to inoculate everyone over the age of 17. Morocco has registered a total of 534,550 COVID-19 infections and 9,319 deaths due to the virus.
